NCT06260358 Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
| NCT ID | NCT06260358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Cervical Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-03-01 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to validate a structured report for cervical cancer anchored to the FIGO staging system. A structured report is hypothesized to aid in uniformly applying FIGO staging, reducing staging discrepancies and improving patient care and outcomes. Furthermore, we believe that the participation of the clinicians will improve the quality of the report to minimize the need for multidisciplinary team discussion
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old; * Overt biopsy-proven diagnosis of cervical cancer, at any stage; * Signed written informed consent to personal data treatment for research purposes Exclusion Criteria: * Age \<18 years old; * Uncertain diagnosis of cervical cancer; * MRI scan not according the standard acquisition protocol (ESUR guidelines); * Patients candidate to non-standard treatments; * Refusal to sign the written informed consent to personal data treatment for research purposes
Contact & Investigator
Evis Sala, Prof
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT06260358 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06260358 currently recruiting?
Yes, NCT06260358 is actively recruiting participants. Contact the research team at luca.russo@unicatt.it for enrollment information.
Where is the NCT06260358 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06260358 clinical trial?
NCT06260358 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Evis Sala, Prof at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.